With global push for COVID-19 vaccines, China aims to win friends and cut deals
Its version of Warp Speed aims not just to stem the COVID-19 pandemic, but to build diplomatic and trade ties
Health
Read our COVID-19 research and news.
-
-
After dosing mix-up, latest COVID-19 vaccine success comes with big question mark
Researchers wonder why lower dose prompted better efficacy in study of vaccine candidate from the University of Oxford and AstraZeneca -
India needs more transparency in its COVID-19 vaccine trials, critics say
Researchers warn secrecy could harm public trust -
With more data on its COVID-19 vaccine, Russian institute offers new evidence of success
Sputnik V vaccine still has more than 90% efficacy in second interim analysis -
For scientists studying ‘disaster fatigue,’ this has been a year like no other
COVID-19 and repeated storms and wildfires have shaped how people perceive risks -
Another COVID-19 vaccine success? Candidate may prevent further coronavirus transmission, too
AstraZeneca/University of Oxford vaccine uses a chimpanzee virus to deliver coronavirus gene and had better efficacy, 90%, when given as a half dose followed by a full dose -
Worlds collide when three Science reporters—and parents—cover coronavirus and schools
Journalists discuss what it’s like to live the stories they’re reporting -
Should researchers shelve plans to deliberately infect people with the coronavirus?
Vaccine successes raise doubts even as planning for first “human challenge” trial continues -
‘Exceptional’ cancer patients yield clues to better drug treatments
Mutations and other changes in tumors appear to explain rare success stories -
Fever, aches from Pfizer, Moderna jabs aren’t dangerous but may be intense for some
“Take Tylenol and suck it up”: side effects show vaccine is working, physicians and researchers say -
As COVID-19 soars in many communities, schools attempt to find ways through the crisis
Early evidence suggests schools can stay open even in the face of significant community spread -
More people are getting COVID-19 twice, suggesting immunity wanes quickly in some
Reinfections give scientists clues about how long protection lasts—and how well vaccines might perform -
Temperature concerns could slow the rollout of new coronavirus vaccines
For now, novel vaccine type needs to be frozen for storage and transport, with one requiring ultracold temperatures of –70°C -
‘Just beautiful’: Another COVID-19 vaccine, from newcomer Moderna, succeeds in large-scale trial
Moderna’s candidate mRNA vaccine protected most people from symptomatic or severe COVID-19, fueling greater optimism that the pandemic can be ended -
‘It’s like politicizing toilet paper.’ A member of Biden’s COVID-19 panel surveys the task ahead
Epidemiologist Céline Gounder sees communication as critical -
Heat is killing more people than ever. Scientists are looking for ways to lower the risk
Along with hot weather, exertion and ill health can heighten danger
Latest News
